Correlation Between Inhibrx and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Ikena Oncology, you can compare the effects of market volatilities on Inhibrx and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Ikena Oncology.
Diversification Opportunities for Inhibrx and Ikena Oncology
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibrx and Ikena is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Inhibrx i.e., Inhibrx and Ikena Oncology go up and down completely randomly.
Pair Corralation between Inhibrx and Ikena Oncology
Given the investment horizon of 90 days Inhibrx is expected to generate 2.56 times more return on investment than Ikena Oncology. However, Inhibrx is 2.56 times more volatile than Ikena Oncology. It trades about -0.11 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.28 per unit of risk. If you would invest 1,525 in Inhibrx on November 2, 2024 and sell it today you would lose (170.00) from holding Inhibrx or give up 11.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Ikena Oncology
Performance |
| Timeline |
| Inhibrx |
| Ikena Oncology |
Inhibrx and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Ikena Oncology
The main advantage of trading using opposite Inhibrx and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |